NuPotential

About:

NuPotential produces cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfers.

Website: http://nupotential.com

Description:

NuPotential produces dedifferentiated cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfer. Its cells are used in therapies that reverse the debilitating effects of diabetes, stroke, heart disease, Alzheimer's disease, Parkinson's disease, and other afflictions, as well as in drug discovery tool applications.

Total Funding Amount:

$725000

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Baton Rouge, Louisiana, United States

Founded Date:

2004-01-01

Founders:

Kenneth Eilertsen

Number of Employees:

1-10

Last Funding Date:

2014-03-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai